Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin or aspirin adjunctive treatment for major depressive disorder in young people
ACTRN12613000112763Phase 3Completed
- Sponsor
- Orygen
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rosuvastatin and aspirin, sponsored by Orygen. Started Jul 2013; status: completed.
02
Drugs
rosuvastatinaspirin
Beyond the preview
Go deeper on ACTRN12613000112763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000112763.